INTRODUCTION
============

Pancreaticoduodenectomy (PD) is currently considered as the treatment choice for carcinoma in periampullary regions. In recent years, this procedure has been rapidly developed and has become safer and more efficient in high volume centers ([@B1]). PD results in a loss of gastric pacemaker and a partial pancreatic resection, and such physiologic consequence leads to a high incidence of postoperative malnutrition. Though many surgeons consider that this postoperative malnutrition is an unavoidable sequence of PD, the importance of nutritional status which influences patients\' quality of life, cannot be ignored.

Postoperative nutritional support was shown to reduce the incidence of complications and to shorten the hospital stay. Recently, early enteral feeding (EEN), in comparison with total parenteral nutrition (TPN), has become a standard management pathway for nutritional support after gastrointestinal surgery ([@B2]-[@B7]). However, clinical data on postoperative EEN after PD are very limited, and reports available are focused only on early postoperative results such as the safety and efficacy of EEN after PD ([@B8]-[@B11]).

In this prospective study, we assessed the postoperative nutritional status of patients who had undergone PD according to the postoperative nutritional method between EEN and TPN, and compared the clinical outcomes of the two modes.

MATERIALS AND METHODS
=====================

Patients
--------

In this open, randomized, single center, parallel group trial, we investigated a long term effect of EEN on postoperative weight change comparing with TPN management in pancreaticoduodenectomy patients. We included patients over 18 yr of age who received PD with malignant periampullary pathology at Gangnam Severance Hospital of Yonsei University Health System between May 2007 and December 2008. Exclusion criteria included: 1) a history of major abdominal or pelvic surgery; 2) patients with metastatic disease and palliative surgery; 3) a history of abdominal or pelvic radiation; 4) patients currently taking steroid or other immunosuppressive medications. Patients receiving preoperative nutritional support were also excluded.

Operative procedures
--------------------

All patients underwent exploratory laparotomy followed by pylorus preserving pancreatoduonectomy (PPPD) or conventional PD as previously described ([@B12]). Pancreaticojejunostomy was performed with duct to mucosa anastomosis in all patients. No pancreaticogastrostomies were performed. End-to-side hepaticojejunostomy was performed 15 cm proximal to the pancreaticojejunostomy with single-layer interrupted sutures. An antecolic duodenojejunostomy (or gastrojejunostomy) was constructed using a two-layered anastomosis. At the end of surgery, patients were randomized in the operating room using a sealed envelop to either EEN or TPN group. Feeding nasojejunal tube was placed into patients randomized to enteral feeding group. Just before closing the wound, 8 Fr feeding tube (Kangaroo, Sherwood Medical, Tullemore, Ireland) with the guide wire in the lumen was inserted by the anesthetist through the naris and pushed down until distal tip of the tube was 20 cm aborally from the duodenojejunostomy or gastrojejunostomy anastomosis. After reconstruction, a closed suction, silicon drain (Jackson-Pratt, Baxter Health Care Corp., Deerfield, IL, USA), was placed from the right upper quadrant posterior to the pancreaticojejunal and biliary anastomoses.

Assessment of nutrition
-----------------------

We examined nutritional status of all patients, and the parameters included weight, laboratory parameters, and the Patient Generated Subjective Global Assessment (PG-SGA) at baseline and postoperative 7th, 14th, 21th, and 90th day by a dietitian. A full diet history was performed, and energy intake and protein intake were calculated. For each component of scored PG-SGA, points (0-4) were awarded depending on the impact of the symptom on nutritional status. A score ≥ 9 indicates a critical need for nutritional intervention.

Postoperative Nutrition Support
-------------------------------

Patients were randomized into two groups, the EEN group to receive postoperative enteral feed and the control group to receive postoperative TPN management ([Fig. 1](#F1){ref-type="fig"}). Enteral feeding (Jevity RTH, Abbott Laboratories, IL, USA) was started within 24 hr postoperatively at a rate of 20 mL/h. The velocity was progressively increased by 20 mL/d until reaching full nutritional goal (25 kcal/kg). Enteral feeding was delivered by an infusion pump for 18 h/day with 6 hr of a rest period.

In the control group, TPN was initiated on the first postoperative day. All patients received TPN solution that has 25 kcal/kg every day. The ratio of glucose to lipid in this solution was 2:1, and nonprotein calorie to nitrogen (kcal/kg) was 100:1. Multivitamins, electrolytes, trace elements and insulin were also included in the TPN solution. All nutrient solutions were prepared daily under aseptic conditions. Infusion was performed through a central venous catheter using an injection micro pump. Enteral or parenteral infusion was continued until the patient\'s oral intake reached approximately 800 kcal/d.

According to the policy of our department, antacid drugs for stress ulcer prophylaxis and octreotide (Sandostatin® 150 µg, Novartis, East Hanover, NJ, USA) was administered to all patients for 7 days postoperatively. Patients were given sips of water between postoperative days 4 and 5 and then proceed to a regular diet within 7 days.

Clinical data and complications
-------------------------------

Members of the surgical staff did not participate in the recorded postoperative complications. PD related complications, such as delayed gastric emptying and pancreatic fistula, were defined by the International Pancreas Study Group ([@B13], [@B14]). Enteral feeding related complications, abdominal cramps and distention, diarrhea (defined as more than three bowel movements per day), vomiting, and aspiration were considered adverse effects. Adverse effects were treated according to the following protocol: 1) abdominal clamping pain was treated first with analgesic drug; in patients with persistent symptoms despite the drug administration, infusion rate was reduced by 20 mL/h or temporarily stopped for 6-12 hr and resumed at a slower rate; 2) abdominal bloating was treated first by prokinetics drug; in patients with persistent symptoms despite the drug administration, infusion rate was reduced by 20 mL/h or temporarily stopped for 6-12 hr and resumed at a slower rate; 3) vomiting was treated by a temporary stop of infusion followed by diagnostic procedures; if there was no intestinal obstruction, infusion was resumed at the slower rate; 4) diarrhea was treated by reducing the infusion rate by 20 mL/h or temporarily stopping it for 6-12 hr, which was resumed at a slower rate; in patients with persistent diarrhea, *Clostridium difficile* infection was always ruled out.

Sample size
-----------

The primary end point of the study was a change in weight. Secondary end-points were rates of delayed gastric empting and pancreatic fistula, duration of hospital stay and change of nutritional index on postoperative days 7, 14, 21, and 90. Postoperative weight loss after PD for periampullary carcinoma was 13.5%, and based on the results achieved in a previous study, the aim of this study was to reduce this weight loss rate by 50% in the group receiving the EEN ([@B13]). Based on this, a sample size of 40 (20 in each group) was necessary to show this difference at a 5% significance with a power of 80%, allowing for a drop out rate of 10%.

Statistical analysis
--------------------

Continuous variables are expressed as mean ± standard deviation (SD). Differences in variables between groups were tested using Student\'s t-test, chi-square test, or Fisher\'s exact test. However, nonparametric tests (Kruskal-Wallis or Mann-Whitney test) were used for variables with skewed distributions. *P* values less than 0.05 were considered statistically significant.

Ethics statement
----------------

The protocol of this was approved by the institutional review board of Yonsei University (3-2007-0022) and was registered on the Clinical Trial.gov (ID no: NCT00809081). Signed informed consent was collected from all recruited patients.

RESULTS
=======

Clinical and preoperative nutritional characteristics of patients
-----------------------------------------------------------------

A total of 40 patients were recruited and randomized to either the TPN or EEN treatment group ([Fig. 2](#F2){ref-type="fig"}). Two patients withdrew from the study because their nasojejunal tubes were accidentally dislodged. Thirty-eight patients (18 EEN and 20 TPN) were analyzed. The mean age of patients was 61.0 yr (± 11.9 yr) and consisted of 19 men and 19 women. Five patients underwent PD, and 33 underwent PPPD. Pathologic diagnoses were pancreatic carcinoma in 14 patients, bile duct cancer in 11, adenocarcinoma of the ampulla of Vater in 11, and duodenal carcinoma in 3. The patient demographics and nutritional parameters of both groups are shown in [Table 1](#T1){ref-type="table"}. The preoperative weight loss significantly changed in the EEN group compared to the TPN group. The two groups showed no significant differences in age, sex, comorbidity, operative blood loss and preoperative nutritional index.

Postoperative course
--------------------

The first day of bowel movement and the time to take a soft diet was significantly shorter in EEN group than in TPN group. Hospital stay was shorter in the EEN group without significance ([Table 2](#T2){ref-type="table"}). There were no cases of hospital mortality. Details of complications are shown in [Table 2](#T2){ref-type="table"}. Overall, 13 of 38 patients (34.2%) had postoperative complications, and the complication rates of two groups were similar to each other. Pancreatic fistula and delayed gastric emptying were the most common complications in this study.

Overall, 3 of 38 patients developed pancreatic fistula as defined by the ISGPF criteria ([@B13]) and the overall incidence was 7.9%. Two (66.7%) patients had grade A, and the other (33.3%) grade C. Pancreatic fistula grade C occurred in the EEN group and was resolved after reinsertion of percutaneous drainage.

Overall, 3 of 38 patients developed delayed gastric emptying (DGE) as defined by the ISGPS criteria ([@B14]) and the overall incidence was 7.9%. Two (66.7%) patients had grade A, and one (33.3%) grade C. Chyle abdomen developed in one patient in each group, which was resolved after temporary reduction of enteral nutrition and oral feeding.

Side Effects of Early Enteral Nutrition
---------------------------------------

There were no aspiration episodes or enteral feeding associated intestinal ischemia. Enteral nutrition was relatively well tolerable to the patients. In EEN group, 4 of 18 patients developed side effects for enteral nutrition. For instance, one patient had diarrhea, one had an abdominal distention, one had a sore throat, and one had nausea and vomiting. All side effects were relieved with a conservative management and a temporary reduction of the amount of enteral nutrition.

Postoperative Nutritional Index
-------------------------------

All nutritional parameters decreased until POD 7 and increased gradually thereafter.

The level of serum albumin, and total protein decreased, and PG-SGA in the early postoperative days and gradually increased in the late postoperative days, but there was no significant difference between two groups ([Table 3](#T3){ref-type="table"}). In the EEN group, body weight gradually decreased until POD 14, but rapidly recovered on POD 21. In contrast, body weight gradually decreased until POD 90 in TPN group (*P* = 0.005). The rapid turnover proteins such as prealbumin and transferrin were more significantly reduced on POD 7 and slowly recovered until POD 90 in the TPN group than in the EEN group ([Fig. 3](#F3){ref-type="fig"}).

DISCUSSION
==========

Traditionally, feeding for patients after gastrointestinal surgery started when flatus or defecation indicated the return of bowel function. However, in recent years, early enteral nutrition in gastrointestinal surgery should be recommended whenever possible. The benefits of EEN have been demonstrated to be more physiological, better preventive in morphologic and functional alteration of the gut system, and less expensive than TPN ([@B15]-[@B17]).

Pancreatic leakage is one of the leading postoperative complications after PD, and it can lead to prolonged hospital stay, increased costs and mortality. Consequently, pancreatic surgeons often prefer postoperative TPN because of the greater risk of pancreatic leakage. However, several reports have suggested that there is no marked difference in pancreatic leakage between EEN and TPN groups ([@B11], [@B18]). Our study is consistent with previous reports that EEN is not a significant factor for pancreatic leakage.

In contrast to the report of Martignoni et al. ([@B11]), there were no significant differences in the occurrence of delayed gastric emptying between the EEN and TPN groups. The main difference between the report of Martignoni et al and the present study was the cyclic infusion of enteral nutrition. Certainly, the cyclic enteral nutrition has advantages for patients over continuous enteral nutrition because it is closer to the natural form of enteral nutrition ([@B19]). Our results demonstrate that EEN does not increase the incidence of delayed gastric emptying after PD. Moreover, EEN promotes faster recovery of bowel peristalsis by reducing time to recanalize for passing gas and feces.

Our results are not consistent with the findings of Brennan et al. ([@B9]), who suggested that TPN was associated with increased infectious complications. The main difference between the report of Brennan et al. and this study was caloric load. They provided high calories at a rate of 30-35 kcal/day, which is considered relative overfeeding today, and this overfeeding may increase postoperative complications when compared with permissive underfeeding ([@B20]). However, a routine use of TPN does not seem to provide any benefit because the high rate of glucose intolerance observed in TPN patients.

There are several methods to deliver enteral nutrition after PD. Nasojejunal tube provides a cost effective and desirable method of enteral nutrition without the morbidity from an additional enterotomy ([@B21]). However, the frequency of nasojejunal tube dislodgement and occlusion was as high as 35% to 100% ([@B22], [@B23]). In the present study, nasojejunal feeding tube was used for all EEN patients, and jejunostomy tube was not used according to our department policy. That is because any unnecessary enterotomy was a potential source of complications. There were no catheter related major complications in the EEN group except for accidentally dislodged nasojejunal tube. In our experience, tube occlusion can be prevented by irrigating it with 20 mL water every 8 hr and after giving medications. The accidentally dislodgement of nasojejunal tube was the most common phenomenon, and special education and attention must be paid to firm nasal fixation. We think that a nasojejunal tube is an effective tool for providing enteral feeding after PD.

In our study, EEN related adverse effect occurred in 22.2% and were resolved by reduction or temporary interruption of infusion. All patients in EEN group reached the nutritional goal without having difficulty by following the infusion protocol. This may be attributed to the fact that our protocol started at a slow flow rate with careful and progressive increase in the feeding volume. Also, this can prevent abdominal distension caused by reaching the nutritional goal too aggressively and early ([@B24]).

In usual practice, the parenteral nutrition begins at goal rates, whereas the enteral feedings advance to goal rate over several days. Although the level of rapid turnover proteins such as prealbumin and transferrin dropped in all the patients after the operation, it was recovered significantly fast in the EEN group in the early postoperative period. These results indicate that EEN modulates a metabolic response, favoring the synthesis of proteins.

It has been shown that patients can maintain a normal body weight after surgery, but it is frequently less than their preoperative body weight ([@B25]-[@B27]). Kozuscheck et al. ([@B28]) reported that 85% of patients who had undergone PPPD reached the preoperative body weight one year after surgery. However, in the present study, preoperative body weight restored in 3 weeks in the EEN group, and recovery of weight 3 weeks after the operation was significantly better in the EEN patients than in the TPN patients. The restoring of the preoperative body weight depends on a many factors including appetite. The mechanisms involved are unclear, but most probably it reflects that EEN stimulate the appetite, so the faster normalization of the dietary intake would be the reason for the significantly faster achievement of the preoperative weight in the EEN group. This finding is important, considering the growing number of elderly patients undergoing PD for periampullary carcinoma.

The use of objective nutrition parameters (anthropometric and biochemical) to assess nutritional status has been questioned in the view of the many non-nutritional factors affecting the results. The scored PG-SGA has been accepted by the Oncology Nutrition Dietetic Practice Group of the American Dietetic Association as the standard for nutrition assessment for cancer patients. The present cut-off score of 9 is appropriate for the initiation of urgent nutritional intervention. In the present study, The PG-SGA score was the highest on POD 14, although other biochemical nutritional indexes were within a normal range on that day. So, we recommend the PG-SGA score should be screened for patients after PD and it may prevent or delay deterioration in the patient\'s nutritional status by providing early nutrition support.

The present study has some limitations. The first, weakness is that patients who had undergone conventional PD were included in this study. Indeed, the operation procedures could attribute to postoperative nutritional status. Some studies have shown that PPPD was associated with better nutritional status postoperatively as compared to conventional PD ([@B18], [@B29], [@B30]). However, we believed that there were no significant differences in the nutritional status because two procedures are equally allocated in the two groups. Second, it is possible that nutritional outcomes of EEN after PD might have been underestimated in this study because of the small sample size study. Therefore, trials with large sample size are required to demonstrate whether postoperative and long-term quality of life is better and whether nutritional outcomes are improved.

In conclusion, postoperative EEN is safe and well tolerated, and shows no negative effect on anastomosis healing. Furthermore, EEN improves early and long term postoperative nutritional status and whole body protein kinetics. It is recommended that the routine postoperative enteral feeding for patients undergoing PD is beneficial and should be a standard of care.
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Clinical and preoperative nutritional parameters
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EEN, Early Enteral Nutrition; TPN, Total Pareneteral Nutrition; PD, Pancreaticoduodenectomy; BMI, Body mass Index; PG-SGA, Patient Generated Subjective Global Assessment.
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Postoperative course
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EEN, Early Enteral Nutrition; TPN, Total Pareneteral Nutrition.
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Prealblumin, total protein, BMI and PG-SGA (score) data preoperative and on postoperative days at 7, 14, 21, and 90 for patients given Early Enteral Nutrition (EEN) versus Total Parenteral Nutrition (TPN). Values are Mean (± standard deviation)
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^\*^There was no significant difference between the EEN and TPN Group at any time point; ^†^BMI was significantly recovered on postoperative day 21 in EEN group compared to TPN group (*P* = 0.005). POD, Postoperative day.
